Literature DB >> 29709605

Catalase A is involved in the response to photooxidative stress in Pseudomonas aeruginosa.

Viviana Teresa Orlandi1, Eleonora Martegani2, Fabrizio Bolognese2.   

Abstract

BACKGROUND: Pseudomonas aeruginosa is the etiological agent of systemic and skin infections that are often difficult to treat. Photodynamic therapy (PDT) and, more recently, phototherapy (PT), are emerging among antimicrobial treatments to be combined with antibiotics. Visible light, either alone or combined with a photosensitizer (PS), elicits photooxidative stress that induces microbial death. The response of bacteria to phototherapy seems to involve the antioxidant machinery. This study relies on the effects of detoxifying catalase A (KatA) in response to PDT and PT-induced photooxidative stress.
METHODS: The photo- and photodynamic inactivation experiments have been targeted at P. aeruginosa PAO1 and its isogenic derivative katA- mutant. The microorganisms were irradiated by a wide-spectrum halogen-tungsten lamp or light-emitting diodes (LEDs). Two photosensitizers, Tetrakis-(1-methyl-4-pyridyl)-21H, 23porphine, tetra-p-tosylate (TMPyP) porphyrin and Toluidine Blue O (TBO), were applied as part of the photodynamic approach.
RESULTS: P. aeruginosa katA- mutant was more sensitive than wild-type strain PAO1 to wide-spectrum light and blue LED (464 nm) treatments. The complementation of KatA, in katA- mutant, restored the light response of wild-type PAO1. Upon TBO treatment and irradiation by visible light (halogen lamp or LED), the sensitivity of katA- mutant was significant higher (p = 0.028 and p = 0.045, respectively) than that of the PAO1 strain.
CONCLUSIONS: This study provides the first description of KatA in the response to photooxidative stress induced by photo- and photodynamic therapy.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blue-light therapy; Catalase A; Photodynamic therapy; Phototherapy; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2018        PMID: 29709605     DOI: 10.1016/j.pdpdt.2018.04.016

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  6 in total

1.  Searching for antimicrobial photosensitizers among a panel of BODIPYs.

Authors:  Viviana Teresa Orlandi; Eleonora Martegani; Fabrizio Bolognese; Enrico Caruso
Journal:  Photochem Photobiol Sci       Date:  2022-04-04       Impact factor: 4.328

Review 2.  Factors Determining the Susceptibility of Bacteria to Antibacterial Photodynamic Inactivation.

Authors:  Aleksandra Rapacka-Zdończyk; Agata Woźniak; Klaudia Michalska; Michał Pierański; Patrycja Ogonowska; Mariusz Grinholc; Joanna Nakonieczna
Journal:  Front Med (Lausanne)       Date:  2021-05-12

Review 3.  Calcium Ion Channels: Roles in Infection and Sepsis Mechanisms of Calcium Channel Blocker Benefits in Immunocompromised Patients at Risk for Infection.

Authors:  John A D'Elia; Larry A Weinrauch
Journal:  Int J Mol Sci       Date:  2018-08-21       Impact factor: 5.923

4.  The Influence of Blue Light and the BlsA Photoreceptor on the Oxidative Stress Resistance Mechanisms of Acinetobacter baumannii.

Authors:  Mariah S Squire; Hope A Townsend; Luis A Actis
Journal:  Front Cell Infect Microbiol       Date:  2022-03-24       Impact factor: 5.293

5.  Photoinactivation of Pseudomonas aeruginosa Biofilm by Dicationic Diaryl-Porphyrin.

Authors:  Viviana Teresa Orlandi; Eleonora Martegani; Fabrizio Bolognese; Nicola Trivellin; Francesco Garzotto; Enrico Caruso
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

Review 6.  Systematic Review and Meta-Analysis of In Vitro Anti-Human Cancer Experiments Investigating the Use of 5-Aminolevulinic Acid (5-ALA) for Photodynamic Therapy.

Authors:  Yo Shinoda; Daitetsu Kato; Ryosuke Ando; Hikaru Endo; Tsutomu Takahashi; Yayoi Tsuneoka; Yasuyuki Fujiwara
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.